Tavilermide Investigational Site — Rapid City, South Dakota

Tavilermide Investigational Site is a clinical research site located in Rapid City, South Dakota, United States 57701.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Tavilermide Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Keratoconjunctivitis Sicca, Dry Eye.

Sponsors: Mimetogen Pharmaceuticals USA, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tavilermide Investigational Site?

Tavilermide Investigational Site has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tavilermide Investigational Site conducted?

Tavilermide Investigational Site has 1 clinical trials on record. Their work covers Keratoconjunctivitis Sicca, Dry Eye.

Is Tavilermide Investigational Site accredited by Crixeo Health?

Tavilermide Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tavilermide Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.